Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Despas

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Annals of Hematology|February 20, 2019
Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemiaLoic Ysebaert, Marie Larcher, Gisele Compaci, et al.
Drug Safety|May 9, 2018
Correction to: Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBaseEmilie Patras de Campaigno, Inès Kebir, Jean-Louis Montastruc, et al.
American Journal of Hematology|May 26, 2022
Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data systemClémentine Vabre, Yoann Zelmat, Martin Gauthier, et al.
BMC Cancer|April 18, 2015
A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survivalCécile Borel, Sébastien Lamy, Gisèle Compaci, et al.
Frontiers in Physiology|February 24, 2018
Intracranial Pressure Is a Determinant of Sympathetic ActivityEric A Schmidt, Fabien Despas, Anne Pavy-Le Traon, et al.
Journal of Medical Economics|December 27, 2019
Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in FranceMichael Mounié, Nadège Costa, Cécile Conte, et al.
Fundamental & Clinical Pharmacology|February 8, 2020
Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population-based study in FranceMartin Gauthier, Cécile Conte, Aurore Palmaro, et al.
The European Respiratory Journal|March 9, 2019
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic studyLucie Cornet, Charles Khouri, Matthieu Roustit, et al.
BMC Cancer|September 7, 2019
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patientsEloïse Berger, Cyrille Delpierre, Fabien Despas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2019
Work adjustments and employment among breast cancer survivors: a French prospective studyFlora Vayr, Marion Montastruc, Frédéric Savall, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Annals of Hematology|February 20, 2019
Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemiaLoic Ysebaert, Marie Larcher, Gisele Compaci, et al.
Drug Safety|May 9, 2018
Correction to: Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBaseEmilie Patras de Campaigno, Inès Kebir, Jean-Louis Montastruc, et al.
American Journal of Hematology|May 26, 2022
Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data systemClémentine Vabre, Yoann Zelmat, Martin Gauthier, et al.
BMC Cancer|April 18, 2015
A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survivalCécile Borel, Sébastien Lamy, Gisèle Compaci, et al.
Frontiers in Physiology|February 24, 2018
Intracranial Pressure Is a Determinant of Sympathetic ActivityEric A Schmidt, Fabien Despas, Anne Pavy-Le Traon, et al.
Journal of Medical Economics|December 27, 2019
Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in FranceMichael Mounié, Nadège Costa, Cécile Conte, et al.
Fundamental & Clinical Pharmacology|February 8, 2020
Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population-based study in FranceMartin Gauthier, Cécile Conte, Aurore Palmaro, et al.
The European Respiratory Journal|March 9, 2019
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic studyLucie Cornet, Charles Khouri, Matthieu Roustit, et al.
BMC Cancer|September 7, 2019
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patientsEloïse Berger, Cyrille Delpierre, Fabien Despas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2019
Work adjustments and employment among breast cancer survivors: a French prospective studyFlora Vayr, Marion Montastruc, Frédéric Savall, et al.
Pageof 9